Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murali Krishna Cherukuri

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
British Journal of Cancer|July 15, 2021
Metabolic reprogramming in prostate cancerFahim Ahmad, Murali Krishna Cherukuri, Peter L Choyke
Neuro-Oncology Advances|November 29, 2023
Monitoring response to a clinically relevant IDH inhibitor in glioma-Hyperpolarized <sup>13</sup>C magnetic resonance spectroscopy approachesDonghyun Hong, Yaewon Kim, Chandrasekhar Mushti, et al.
Magnetic Resonance in Medicine|January 26, 2011
Detecting response of rat C6 glioma tumors to radiotherapy using hyperpolarized [1- 13C]pyruvate and 13C magnetic resonance spectroscopic imagingSam E Day, Mikko I Kettunen, Murali Krishna Cherukuri, et al.
PNAS Nexus|April 24, 2023
Mitoribosome sensitivity to HSP70 inhibition uncovers metabolic liabilities of castration-resistant prostate cancerFrank J Echtenkamp, Ryo Ishida, Genesis M Rivera-Marquez, et al.
Biorxiv : the Preprint Server for Biology|October 1, 2025
Metabolic and imaging phenotypes associated with <i>RB1</i> and <i>TP53</i> loss in prostate cancerFahim Ahmad, Margaret White, Kazutoshi Yamamoto, et al.
Neoplasia (New York, N.Y.)|October 8, 2025
Metabolic and imaging phenotypes associated with RB1 and TP53 loss in prostate cancerFahim Ahmad, Margaret White, Kazutoshi Yamamoto, et al.
Neuro-Oncology|October 31, 2019
Metabolic reprogramming associated with aggressiveness occurs in the G-CIMP-high molecular subtypes of IDH1mut lower grade gliomasVictor Ruiz-Rodado, Tathiane M Malta, Tomohiro Seki, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
British Journal of Cancer|July 15, 2021
Metabolic reprogramming in prostate cancerFahim Ahmad, Murali Krishna Cherukuri, Peter L Choyke
Neuro-Oncology Advances|November 29, 2023
Monitoring response to a clinically relevant IDH inhibitor in glioma-Hyperpolarized <sup>13</sup>C magnetic resonance spectroscopy approachesDonghyun Hong, Yaewon Kim, Chandrasekhar Mushti, et al.
Magnetic Resonance in Medicine|January 26, 2011
Detecting response of rat C6 glioma tumors to radiotherapy using hyperpolarized [1- 13C]pyruvate and 13C magnetic resonance spectroscopic imagingSam E Day, Mikko I Kettunen, Murali Krishna Cherukuri, et al.
PNAS Nexus|April 24, 2023
Mitoribosome sensitivity to HSP70 inhibition uncovers metabolic liabilities of castration-resistant prostate cancerFrank J Echtenkamp, Ryo Ishida, Genesis M Rivera-Marquez, et al.
Biorxiv : the Preprint Server for Biology|October 1, 2025
Metabolic and imaging phenotypes associated with <i>RB1</i> and <i>TP53</i> loss in prostate cancerFahim Ahmad, Margaret White, Kazutoshi Yamamoto, et al.
Neoplasia (New York, N.Y.)|October 8, 2025
Metabolic and imaging phenotypes associated with RB1 and TP53 loss in prostate cancerFahim Ahmad, Margaret White, Kazutoshi Yamamoto, et al.
Neuro-Oncology|October 31, 2019
Metabolic reprogramming associated with aggressiveness occurs in the G-CIMP-high molecular subtypes of IDH1mut lower grade gliomasVictor Ruiz-Rodado, Tathiane M Malta, Tomohiro Seki, et al.
Pageof 1